quercetin
cultur
target
cell
pathogen
exert
antipathogen
activ
wide
varieti
virus
bacteria
smallscal
human
quercetin
supplement
studi
produc
conflict
result
regard
quercetin
effect
upper
respiratori
tract
infect
rate
littl
known
regard
appropri
human
dose
purpos
random
doubleblind
placebocontrol
trial
measur
influenc
two
quercetin
dose
mgday
compar
placebo
upper
respiratori
tract
infect
urti
rate
larg
commun
group
n
subject
vari
wide
age
year
subject
ingest
supplement
week
log
urti
symptom
daili
basi
use
wisconsin
upper
respiratori
symptom
survey
wurss
signific
group
differ
measur
urti
outcom
subject
combin
analyz
separ
gender
bodi
mass
index
age
categori
regress
analysi
reveal
strongest
interact
effect
group
statu
selfreport
fit
level
separ
analysi
subject
year
age
older
rate
top
half
entir
group
fit
level
n
show
lower
urti
sever
reduct
p
urti
total
sick
day
reduct
p
group
compar
placebo
summari
subject
combin
quercetin
supplement
week
signific
influenc
urti
rate
symptomatolog
compar
placebo
reduct
urti
total
sick
day
sever
note
middl
age
older
subject
ingest
mg
quercetinday
week
rate
physic
fit
human
ill
upper
respiratori
tract
infect
urti
occur
frequent
acut
infect
nose
paranas
sinus
pharynx
larynx
trachea
bronchi
exemplifi
common
cold
virus
predominantli
rhinoviru
influenza
viru
coronaviru
adenoviru
parainfluenza
viru
respiratori
syncyti
viru
causal
agent
urti
rhinoviru
account
largest
number
case
accord
nation
institut
allergi
infecti
diseas
averag
adult
cold
year
young
children
suffer
high
incid
noninfluenzarel
viral
respiratori
infect
impart
estim
billion
burden
direct
indirect
cost
us
economi
prevent
treatment
urti
supplement
herb
plant
extract
isol
plant
molecul
activ
area
research
clinic
trial
typic
led
mix
confus
result
quercetin
antioxid
flavonoid
found
fruit
veget
shown
exert
strong
antivir
activ
cultur
target
cell
causal
agent
urti
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
sever
adenovirus
quercetin
also
report
influenc
immun
function
via
upregul
howev
nearli
known
quercetinrel
effect
come
vitro
studi
design
given
vitro
antipathogen
immunomodulatori
effect
quercetin
seri
studi
conduct
determin
whether
quercetin
supplement
offset
exerciseinduc
immun
perturb
urti
risk
one
studi
investig
effect
quercetin
infect
rate
mice
use
viralchalleng
studi
design
data
studi
indic
mgkg
quercetin
feed
day
prior
inocul
dose
apuerto
influenza
viru
offset
exerciseinduc
increas
morbid
symptom
sever
mortal
howev
studi
examin
measur
immun
function
unclear
whether
effect
due
direct
antivir
activ
augment
immun
function
quercetin
doubleblind
placebocontrol
studi
cyclist
immun
function
analyz
parallel
incid
sever
urti
conduct
research
team
result
trial
show
supplement
mgday
quercetin
week
significantli
increas
plasma
quercetin
level
reduc
selfreport
incid
urti
period
follow
day
exhaust
exercis
immun
dysfunct
inflamm
oxid
stress
howev
affect
quercetin
suggest
quercetin
may
exert
effect
via
direct
antivir
activ
least
within
context
studi
design
base
studi
result
hypothes
longterm
quercetin
supplement
would
reduc
urti
incid
symptomatolog
gener
commun
especi
among
highrisk
group
young
adult
femal
individu
risk
factor
urti
obes
poor
physic
fit
high
level
mental
stress
larg
number
subject
recruit
allow
investig
quercetin
potenti
influenc
urti
rate
variou
subgroup
differ
gender
age
bodi
mass
index
physic
fit
recent
exposur
stress
event
vitro
antivir
properti
quercetin
shown
potenti
ascorb
unpublish
data
quercegen
pharma
indic
absorpt
quercetin
enhanc
addit
vitamin
c
niacin
supplement
formula
use
studi
combin
quercetin
mgday
vitamin
c
mgday
niacin
mgday
male
femal
subject
n
year
age
recruit
via
mass
advertis
commun
half
subject
studi
period
januari
april
second
half
august
novemb
subject
noninstitution
women
exclud
pregnant
lactat
exclus
criteria
employ
diseas
nondiseas
subject
admit
studi
monitor
diseas
statu
medic
usag
written
inform
consent
obtain
subject
appalachian
state
univers
institut
review
board
approv
experiment
procedur
recruit
subject
stratifi
gender
male
femal
age
young
adult
year
age
middleag
elderli
bodi
mass
index
bmi
group
normal
overweight
obes
kgm
ensur
represent
variou
subgroup
subject
agre
avoid
supplement
contain
quercetin
also
agre
make
major
chang
dietari
exercis
habit
durat
studi
restrict
place
diet
supplement
usag
medic
subject
random
one
three
group
mg
quercetinday
mg
quercetinday
placebo
supplement
administ
use
doubleblind
procedur
subject
ingest
two
soft
chew
supplement
twice
daili
upon
awaken
pm
last
meal
day
studi
period
supplement
prepar
nutravail
technolog
chantilli
va
usa
quercegen
pharma
newton
usa
soft
individu
wrap
chew
gpiec
contain
either
mg
quercetin
mg
vitamin
c
ascorb
acid
sodium
ascorb
mg
niacin
nicotinamid
kcal
sugar
carnauba
wax
soy
lecithin
corn
starch
glycerin
palm
oil
base
color
fd
c
yellow
placebo
supplement
prepar
exactli
way
minu
quercetin
vitamin
c
niacin
previou
studi
perform
lab
use
similar
supplement
placebo
formula
complianc
supplement
regimen
monitor
subject
complet
adher
survey
month
subject
indic
noncompli
drop
studi
subject
start
supplement
first
blood
sampl
continu
week
subject
complet
monthli
log
verifi
physic
activ
diet
statu
chang
diseas
statu
medic
use
gastrointestin
constip
heartburn
bloat
diarrhea
nausea
vomit
skin
rash
dryness
flush
allergi
mental
energi
headach
stress
focusconcentr
symptom
two
week
prior
first
lab
visit
studi
subject
provid
demograph
lifestyl
habit
inform
use
survey
post
surveymonkeycom
portland
usa
inform
dietari
pattern
obtain
semiquantit
food
frequenc
questionnair
food
group
includ
fruit
veget
cereal
meat
dairi
fat
exercis
habit
assess
answer
categor
question
deal
leisuretim
work
activ
physic
fit
level
selfreport
use
tenpoint
likert
scale
subject
group
fit
tertil
accord
selfreport
level
correspond
low
fit
medium
fit
high
fit
recent
exposur
stress
event
assess
answer
question
past
month
would
say
experienc
lot
moder
rel
littl
almost
stress
subject
group
stress
tertil
base
answer
subject
answer
rel
littl
almost
stress
group
togeth
low
stress
tertil
subject
height
measur
stadiomet
bodi
mass
determin
use
tanita
scale
tanita
arlington
height
il
usa
subject
donat
blood
sampl
supplement
period
morn
overnight
fast
blood
sampl
taken
antecubit
vein
subject
seat
posit
separ
plasma
sampl
immedi
flashfrozen
liquid
nitrogen
store
c
total
plasma
quercetin
quercetin
primari
conjug
heparintr
blood
sampl
measur
previous
describ
wisconsin
upper
respiratori
symptom
survey
wurss
use
assess
urti
incid
symptomatolog
construct
valid
wurss
support
measur
reliabl
respons
import
patient
converg
includ
item
assess
symptom
nine
item
assess
function
impair
one
item
assess
global
sever
global
chang
subject
fill
onepag
end
day
studi
respons
record
studi
urti
sever
score
calcul
sum
daili
urti
global
sever
score
sick
mild
urti
sever
urti
symptom
score
period
calcul
sum
symptom
score
day
entri
symptom
mild
sever
urti
daili
activ
score
calcul
sum
nine
function
impair
entri
mildli
sever
statist
analys
perform
use
spss
pc
v
softwar
spss
inc
chicago
il
usa
urti
outcom
compar
group
placebo
within
group
gender
bmi
categori
normal
weight
kgm
overweight
kgm
obes
kgm
age
categori
year
data
express
mean
sem
compar
group
use
oneway
anova
tukey
post
hoc
analysi
stepwis
linear
regress
analysi
use
determin
effect
age
bmi
demograph
lifestyl
factor
urti
outcom
measur
plasma
quercetin
data
analyz
use
group
time
repeat
measur
anova
group
design
post
hoc
analysi
use
bonferroni
adjust
independ
ttest
contrast
pretopostsupplement
chang
placebo
test
p
consid
signific
subject
rang
age
year
larg
varianc
bodi
mass
composit
tabl
subject
recruit
studi
complet
trial
among
dropout
placebo
group
fail
take
supplement
andor
adher
test
procedur
report
advers
symptom
take
supplement
chang
bodi
mass
composit
note
cours
studi
interact
effect
indic
group
differ
subject
characterist
data
shown
thirtyseven
percent
subject
report
past
current
histori
one
chronic
diseas
hypertens
arthriti
cancer
cardiovascular
diseas
diabet
group
differ
chronic
diseas
statu
p
plasma
quercetin
quercetin
group
mgday
increas
significantli
placebo
level
group
time
interact
effect
p
fig
monthli
symptom
log
reveal
group
differ
time
gastrointestin
skin
allergi
mental
symptom
signific
correl
found
plasma
quercetin
level
dietari
variabl
data
shown
quercetinurti
relationship
outcom
measur
differ
first
second
cohort
studi
thu
data
combin
analysi
subject
combin
signific
group
differ
measur
total
number
day
urti
symptom
urti
sever
urti
symptom
score
studi
period
tabl
separ
analysi
subject
year
age
older
rate
top
half
entir
group
fit
level
n
show
lower
urti
sever
reduct
p
urti
total
sick
day
reduct
p
group
compar
placebo
fig
b
analys
age
gender
bmi
fit
combin
show
signific
group
effect
subject
combin
decreas
sick
day
symptomatolog
sever
symptom
score
relat
male
fig
plasma
quercetin
level
supplement
placebo
mgday
mgday
quercetin
p
compar
placebo
medium
high
c
stress
low
rel
littl
almost
stress
medium
moder
high
lot
fruit
intak
low
servingday
medium
servingsday
high
servingsday
gender
p
increas
age
p
bmi
tabl
measur
healthi
lifestyl
increas
selfreport
fit
level
daili
fruit
intak
significantli
relat
fewer
urti
sick
day
decreas
symptomatolog
tabl
final
subject
report
high
stress
month
prior
studi
experienc
significantli
urti
sick
day
increas
symptomatolog
subject
report
low
moder
stress
tabl
subject
high
stress
group
n
quercetin
supplement
mgday
tend
decreas
number
urti
sick
day
symptomatolog
p
data
indic
supplement
mgday
quercetin
addit
mgday
vitamin
c
mgday
niacin
week
significantli
increas
plasma
quercetin
level
result
advers
symptom
effect
total
number
urti
sick
day
urti
sever
urti
symptom
score
lack
quercetinrel
effect
urti
remain
even
adjust
gender
age
bmi
although
urti
measur
global
affect
quercetin
supplement
total
urti
sick
day
symptom
sever
reduc
onethird
middleag
older
subject
rate
top
half
group
fit
prior
research
perform
lab
found
cyclist
supplement
mgday
quercetin
exercis
heavili
three
consecut
day
experienc
signific
reduct
urti
incid
compar
placebo
protect
effect
note
period
follow
bout
exhaust
exercis
athlet
increas
risk
urti
exerciseinduc
immun
perturb
lead
us
hypothesi
quercetinrel
effect
urti
would
like
found
highrisk
group
present
studi
howev
signific
reduct
urti
durat
sever
associ
quercetin
supplement
experienc
subject
rate
physic
fit
surpris
find
older
fitter
subject
alreadi
low
risk
urti
contrari
hypothesi
effect
quercetin
supplement
urti
found
highrisk
group
although
trend
toward
benefici
effect
note
subject
report
high
level
mental
stress
month
prior
begin
studi
note
current
studi
design
distinguish
whether
reduct
total
number
urti
day
symptom
sever
due
quercetin
vitamin
c
niacin
synergist
effect
three
compon
howev
author
consid
unlik
protect
effect
note
attribut
vitamin
c
niacin
includ
supplement
vitamin
c
shown
reduc
risk
urti
gener
commun
furthermor
dosag
niacin
use
two
supplement
formula
rel
low
us
rda
respect
niacin
link
urti
risk
sever
differ
studi
design
point
compar
result
trial
previou
studi
first
exercis
studi
previous
perform
research
team
design
studi
effect
quercetin
supplement
urti
incid
time
acut
rather
chronic
stress
also
subject
rate
high
physic
fit
level
current
studi
exercis
frequent
also
ate
serv
fruit
per
day
reduc
bmi
level
compar
subject
lower
fit
tertil
thu
physic
fit
rate
broader
implic
regard
overal
habit
quercetin
supplement
ad
benefici
influenc
age
physic
fit
level
reduc
urti
symptomatolog
synerg
deserv
explor
quercetin
shown
exert
strong
antipathogen
effect
sever
causal
agent
urti
cultur
studi
howev
present
studi
quercetin
supplement
global
effect
total
number
urti
sick
day
symptomatolog
find
may
explain
potenti
reduct
quercetin
antivir
activ
due
metabol
biotransform
follow
ingest
quercetin
present
fruit
veget
watersolubl
quercetin
glycosid
chen
et
al
demonstr
one
glycosid
inhibit
proteas
essenti
viral
replic
sarscov
studi
vitro
quercetin
glycosid
consum
howev
sugar
moieti
cleav
small
intestin
releas
lipidsolubl
aglycon
form
quercetin
chiang
et
al
use
aglycon
quercetin
cultur
studi
found
also
exhibit
strong
antivir
effect
inhibit
earli
viral
replic
doserespons
manner
howev
aglycon
quercetin
either
methyl
sulphat
glucuronid
phase
ii
metabol
liver
conjug
form
quercetin
predomin
found
blood
compart
one
studi
found
exhibit
strong
antivir
activ
polio
viru
work
need
examin
whether
quercetin
exert
antipathogen
activ
conjug
form
thu
although
vitro
studi
point
potenti
valu
quercetin
antivir
agent
affect
quercetin
conjug
requir
studi
quercetin
vivo
role
augment
immun
function
also
appear
limit
report
previou
studi
studi
increas
number
day
urti
overal
symptomatolog
relat
femal
gender
younger
age
selfreport
high
level
mental
stress
low
fruit
intak
low
physic
fit
level
bmi
find
consist
publish
studi
link
urti
risk
age
gender
exposur
stress
life
event
counter
studi
link
urti
risk
obes
sever
random
trial
epidemiolog
studi
compar
urti
incid
group
across
continuum
selfselect
physic
activ
fit
level
agreement
data
report
reduct
among
activ
physic
fit
group
limit
data
support
moder
reduct
urti
risk
higher
fruit
intak
especi
combin
veget
summari
quercetin
supplement
dose
mgday
week
significantli
increas
plasma
quercetin
level
report
side
effect
found
decreas
total
number
urti
sick
day
reduc
symptomatolog
subject
contrari
hypothesi
strongest
quercetinurti
relat
effect
seen
rel
lowrisk
group
older
subject
rate
physic
fit
subject
group
ingest
mgday
quercetin
experienc
onethird
reduct
total
number
urti
sick
day
urti
sever
compar
placebo
futur
work
need
elucid
potenti
connect
quercetin
affect
exercis
statu
work
support
grant
cocacola
quercegen
pharma
cocacola
quercegen
pharma
involv
design
studi
role
collect
analysi
interpret
data
involv
write
report
decis
submit
paper
public
